Okina et al. studied the expression of REV-7 protein in 83 tissue samples from patients diagnosed with diffuse large B‐cell lymphoma who underwent rituximab and CHOP chemotherapy (R-CHOP) [16]. The gene discussed is MAD2L2; the disease is diffuse large B-cell lymphoma.